The DOI matches its Crossref record.
Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study
Abstract
Article abstract—We followed 828 nondemented residents of Hisayama Town, Kyushu, Japan, aged 65 years or older (88.3% of the elderly population) for 7 years starting in 1985 in order to determine the type-specific incidence of dementia and its risk factors in the general Japanese population. Only two subjects were lost to the follow-up, during which period 103 subjects developed dementia. Morphologic examination of the brains of 89 subjects (86.4%) was made by autopsy or CT. We made the initial diagnosis of dementia based on the DSM-111-R criteria, with the diagnoses of vascular dementia (VD) being based on the NINDS-AIREN criteria and Alzheimer9s disease (AD) on the NINCDS-ADRDA criteria. The incidence of VD and AD increased with age for both sexes. The age-adjusted total incidence (per 1,000 person-years) of dementia was 19.3 for men and 20.9 for women. The corresponding rates for VD were 12.2 for men and 9.0 for women, and for AD, 5.1 for men and 10.9 for women. Among the VD subjects whose brain morphology we examined, the most frequent type of stroke was multiple lacunar infarcts (42%), but half these subjects lacked a stroke episode in their histories. Multivariate analysis showed that age, prior stroke episodes, systolic blood pressure, and alcohol consumption were significant independent risk factors for the occurrence of VD. In contrast, age and a low score on Hasegawa9s dementia scale were significant risk factors for AD, and physical activity was a significant preventive factor for AD. Our findings suggest that asymptomatic stroke is an important factor in the development of VD, with age, prior stroke episodes, systolic blood pressure, and alcohol consumption being independent risk factors for its occurrence. Age and a low scare on Hasegawa9s dementia scale are significant risk factors for AD, with moderate physical activity having a statistically significant preventive effect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperinsulinemia is a risk factor for diabetes, and numerous studies have shown a relation of diabetes with higher Alzheimer’s disease risk.”
From Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease (2008) · cites this paper as Yoshitake et al., 1995
Citations
Cited by
Sorted by citations
Items 401–500 of 826
Central nervous system involvement in diabetes mellitus
Selvarajah, D., & Tesfaye, S. H. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0075-y · Cited by 42
Annear, M. J., Otani, J., & Li, J. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12911 · Cited by 41
Jeong, M.-K., Park, K. W., Ryu, J.-K., Kim, G.-M., Jung, H.-H., & Park, H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18126240 · Cited by 46
Apolipoprotein E variants and cognition in healthy individuals: A critical opinion
Savitz, J. B., Solms, M., & Ramesar, R. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.10.006 · Cited by 41
Prevention of Alzheimer's disease
Szekely, C. A., Breitner, J. C. S., & Zandi, P. P. (2007) · International Review of Psychiatry · doi:10.1080/09540260701797944 · Cited by 41
Gold, G., Giannakopoulos, P., & Bouras, C. (1998) · European Neurology · doi:10.1159/000007968 · Cited by 40
Auchus, A. P., Chen, C. P. L. H., Sodagar, S. N., Thong, M., & Sng, E. C. S. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00272-1 · Cited by 40
Yao, H., Takashima, Y., Mori, T., Uchino, A., Hashimoto, M., Yuzuriha, T., Miwa, Y., & Sasaguri, T. (2009) · Hypertension Research · doi:10.1038/hr.2009.65 · Cited by 40
Neurocognitive Changes and Their Neural Correlates in Patients with Type 2 Diabetes Mellitus
Lee, J. H., Choi, Y., Jun, C. S., Hong, Y. S., Cho, H. B., Kim, J. E., & Lyoo, I. K. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.2.112 · Cited by 43
Yoshitani, K., Kawaguchi, M., Sugiyama, N., et al. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200106000-00003 · Cited by 40
Zhang, X., Li, Q., Cong, W., Mu, S., Zhan, R., Zhong, S., Zhao, M., Zhao, C., Kang, K., & Zhou, Z. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102127 · Cited by 47
Nakahori, N., Sekine, M., Yamada, M., Tatsuse, T., Kido, H., & Suzuki, M. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0791-6 · Cited by 39
The impact of risk factors for dementia in China
Liu, Y., Zhang, S., Tomata, Y., Nurrika, D., Sugawara, Y., & Tsuji, I. (2020) · Age and Ageing · doi:10.1093/ageing/afaa048 · Cited by 39
“These two factors together could potentially increase the risk for dementia [28].”
BackgroundWu‐Chung, E. L., Leal, S. L., Denny, B. T., Cheng, S. L., & Fagundes, C. P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.010 · Cited by 49
Neuroinflammatory Cytokines - The Common Thread in Alzheimer Pathogenesis
Griffin, W. S. T., Barger, S. W., & Chairman, D. P. A. V. (2011) · European Neurological Review · doi:10.17925/enr.2011.06.02.89 · Cited by 39
Hashimoto, M., Araki, Y., Takashima, Y., Nogami, K., Uchino, A., Yuzuriha, T., & Yao, H. (2016) · Brain and Behavior · doi:10.1002/brb3.620 · Cited by 45
The prevalence and predictors of cognitive impairment in type 2 diabetic population of Punjab, India
Khullar, S., Kaur, G., Dhillon, H., Sharma, R., Mehta, K., Singh, M., & Singh, P. (2016) · Journal of Social Health and Diabetes · doi:10.4103/2321-0656.193996 · Cited by 39
Iqbal, K., Hasanain, M., Ahmed, J., Iqbal, A., Rathore, S. S., Monis, A., Baig, M. D., & Haq, Z. G. U. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2021.11.035 · Cited by 39
Hypertension and Cognitive Function in the Elderly
Cherubini, A., Lowenthal, D. T., Paran, E., Mecocci, P., WILLIAMS, L. S., & Senin, U. (2007) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3180ed6b8f · Cited by 38
Muraki, I., Yamagishi, K., Ito, Y., Fujieda, T., Ishikawa, Y., Miyagawa, Y., Okada, K., Sato, S., Kitamura, A., Shimamoto, T., et al. (2008) · Cerebrovascular Diseases · doi:10.1159/000113861 · Cited by 38
Incidence of dementia in a Munich community sample of the oldest old
Fichter, M. M., Schröppel, H., & Meller, I. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02189026 · Cited by 38
Karamanova, N., Truran, S., Serrano, G. E., Beach, T. G., Madine, J., Weissig, V., Davies, H. A., Veldhuizen, J., Nikkhah, M., Hansen, M., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014810 · Cited by 40
“A ge is the most important risk factor for cerebrovascular disease (CVD) and cognitive dysfunction disorders, including vascular dementia (VaD).(1) Even in the absence of traditional cardiovascular risk factors, aging results in well-”
BackgroundEtiology of parkinsonism in a Brazilian movement disorders clinic
Cardoso, F., Camargos, S., & SILVA, G. A., Jr. (1998) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x1998000200001 · Cited by 37
Zhang, X., Geng, T., Li, N., Wu, L., Wang, Y., Zheng, D., Guo, B., & Wang, B. (2022) · Nutrients · doi:10.3390/nu15010069 · Cited by 35
“Likewise, many studies have reported no significant association between lower HDL-C concentration with an increased risk of VaD risk [9,38,40,41].”
BackgroundFactors associated with persistence of cholinesterase inhibitor treatments in the elderly
Pariente, A., Pinet, M., Moride, Y., Merlière, Y., Moore, N. D., & Fourrier‐Réglat, A. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1933 · Cited by 36
Vascular-ischemic dementia: an update
Jellinger, K. A. (2002) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6139-5_1 · Cited by 36
Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease
Jolivalt, C. G., Calcutt, N. A., & Masliah, E. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.032 · Cited by 34
Detection of Mild Dementia in Community Surveys
Herlitz, A. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550150075019 · Cited by 35
Kimura, R., Okouchi, M., Kato, T., Imaeda, K., Okayama, N., Asai, K., & Joh, T. (2012) · Neuroendocrinology · doi:10.1159/000345529 · Cited by 33
Thrombolytic Therapy for Acute Ischemic Stroke: Past and Future
Shibata, K., Hashimoto, T., Miyazaki, T., Miyazaki, A., & Nobe, K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190319115018 · Cited by 34
The effect of occupational physical activity on dementia: Results from the Copenhagen Male Study
Nabe‐Nielsen, K., Holtermann, A., Gyntelberg, F., Garde, A. H., Islamoska, S., Prescott, E., Schnohr, P., & Hansen, Å. M. (2020) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13846 · Cited by 34
Cerebrovascular disease and dementia
Onyike, C. U. (2006) · International Review of Psychiatry · doi:10.1080/09540260600935421 · Cited by 34
Apolipoprotein Genotype for Prediction of Alzheimer's Disease in Older Japanese: The Hisayama Study
Ohara, T., Ninomiya, T., Kubo, M., Hirakawa, Y., Doi, Y., Hata, J., Iwaki, T., Kanba, S., & Kiyohara, Y. (2011) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03405.x · Cited by 32
Self-citationPrevalence and incidence of Alzheimers disease and other dementing disorders in Pylea, Greece
Tsolaki, M., Fountoulakis, C., Pavlopoulos, I., Chatzi, E., & Kazis, A. (1999) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331759901400308 · Cited by 33
Gender Differences in Stroke Risk Among the Elderly After Coronary Artery Surgery
Gotō, T., Baba, T., Ito, A., Maekawa, K., & Koshiji, T. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000263279.07361.1f · Cited by 34
“003 40–60 100 (20) 31 (14) 40 24 (5) 3 (1) No.”
InfluentialHanon, O., Seux, M. L., Lenoir, H., Rigaud, A.-S., & Forette, F. (2003) · Current Cardiology Reports · doi:10.1007/s11886-003-0104-2 · Cited by 34
Obesity in Late-Life as a Protective Factor Against Dementia and Dementia-Related Mortality
Natale, G., Zhang, Y., Hanes, D. W., & Clouston, S. (2023) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221111658 · Cited by 35
“44 Our findings support prior works that show that unintentional weight loss at any age may indicate neurological disease and increased all-cause mortality.”
ResultMahinrad, S., Sorond, F. A., & Gorelick, P. B. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2204148 · Cited by 34
Bonnet, M. C., Dilharreguy, B., Michèle Allard, A., Deloire, M. S. A., Petry, K. G., & Brochet, B. (2008) · Human Brain Mapping · doi:10.1002/hbm.20575 · Cited by 32
The New Epidemic: Frequency of Dementia in the Rotterdam Study
Breteler, M. M. B., Ott, A., & Albert Hofman, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022423 · Cited by 32
Tyas, S., Pederson, L. L., & Koval, J. J. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(00)00061-2 · Cited by 32
Mid-Life Proteinuria and Late-Life Cognitive Function and Dementia in Elderly Men
Higuchi, M., Chen, R., Abbott, R. D., Bell, C., Launer, L. J., Ross, G. W., Petrovitch, H., & Masaki, K. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000082 · Cited by 32
Dementia prevention and reserve against neurodegenerative disease
Perneczky, R. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/rperneczky2 · Cited by 40
Shadlen, M., Larson, E. B., Gibbons, L. E., Rice, M. M., McCormick, W. C., Bowen, J., McCurry, S. M., & Graves, A. B. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49269.x · Cited by 31
Li, H., Yang, S. R., Wu, J. H., Ji, L., Zhu, L., Cao, L., Huang, J., Jiang, Q., Jiang, W., Liu, M., et al. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26321 · Cited by 34
Chung, H. S., Lee, J. S., Kim, J. A., Roh, E., Lee, Y., Hong, S. H., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, S. G., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00441 · Cited by 31
Classification of dementia and Alzheimer's disease
Morris, J. C. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb05871.x · Cited by 30
Falsetti, L., Viticchi, G., Zaccone, V., Guerrieri, E., Moroncini, G., Luzzi, S., & Silvestrini, M. (2022) · Biomedicines · doi:10.3390/biomedicines10020439 · Cited by 30
Hanyu, H., Shimuzu, S., Tanaka, Y., Takasaki, M., Koizumi, K., & Abe, K. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.02.011 · Cited by 30
“Although it is generally assumed that in Japan vascular dementia is more frequent [33,34], our patients were old (the mean age was approximately 78 years) enough to consider concomitant AD pathology.”
BackgroundMielke, M. M., Xue, Q., Zhou, J. Q., Chaves, P. H. M., Fried, L. P., & Carlson, M. C. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.6.619 · Cited by 31
The incidence of dementia in an Australian community population: the Sydney older persons study
Waite, L. M., Broe, G. A., Grayson, D. A., & Creasey, H. M. (2001) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.404 · Cited by 30
Prevalence of Alzheimer's Dementia and Its Risk Factors in Community-Dwelling Elderly Koreans
Choi, S.-J., Jung, S. S., You, Y.-S., Shin, B.-S., Kim, J.-E., Yoon, S.-W., Jeon, D.-W., Baek, J. H., Park, S., Lee, J.-G., et al. (2008) · Psychiatry Investigation · doi:10.4306/pi.2008.5.2.78 · Cited by 30
Blood pressure and dementia in the elderly: epidemiologic perspectives
Guo, Z., Viitanen, M. H., Fratiglioni, L., & Winblad, B. G. (1997) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(97)87729-3 · Cited by 28
Bickel, H. (1999) · Springer eBooks · doi:10.1007/978-3-642-60228-3_2 · Cited by 30
Li, Z., Yang, Y., Liu, Y., Wang, X., Ping, F., Xu, L., Zhang, H., Li, W., & Li, Y. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102868 · Cited by 35
Baker, L. D., Pa, J., Katula, J. A., Aslanyan, V., Salmon, D. P., Jacobs, D. M., Chmelo, E. A., Hodge, H., Morrison, R. H., Matthews, G., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14586 · Cited by 41
Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders
Borja, A. J., Hancin, E. C., Zhang, V., Revheim, M.-E. R., & Alavi, A. A. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04697-y · Cited by 30
“Individuals at the highest risk for vascular dementia are those with a recent history of stroke or transient ischemic attacks [18, 19].”
BackgroundSuzuki, K., Shinohara, M., Uno, Y., Tashiro, Y., Gheni, G., Yamamoto, M., Fukumori, A., Shindo, A., Mashimo, T., Tomimoto, H., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02135-w · Cited by 29
Dementia and Alzheimer's disease: A new direction. The 2010 Jay L. Foster Memorial Lecture
Kuller, L. H., & López, O. L. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.901 · Cited by 31
Diabetes and Cognitive Dysfunction
Sims‐Robinson, C., Kim, B., & Feldman, E. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00013-6 · Cited by 30
Treatment of hypertension and prevention of dementia
Hanon, O., & Forette, F. (2005) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.06.022 · Cited by 30
Yao, H., Takashima, Y., Araki, Y., Uchino, A., Yuzuriha, T., & Hashimoto, M. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.07.018 · Cited by 28
Rosado-Artalejo, C., Carnicero, J. A. C., Losa‐Reyna, J., et al. (2017) · The journal of nutrition health & aging · doi:10.1007/s12603-017-0895-2 · Cited by 28
Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia
Migrino, R. Q., Karamanova, N., Truran, S., Serrano, G. E., Davies, H. A., Madine, J., & Beach, T. G. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12072 · Cited by 28
Zingel, R., Bohlken, J., Riedel-Heller, S. G., Barth, S., & Kostev, K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-201176 · Cited by 28
Ru, M., Brauer, M. D., Lamarque, J., & Shindell, D. T. (2021) · GeoHealth · doi:10.1029/2020gh000356 · Cited by 28
Yamaguchi, S., Matsubara, M., & Kobayashi, S. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1593-9 · Cited by 28
Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors
Pariente, A., Fourrier‐Réglat, A., Bazin, F., Ducruet, T., Dartigues, J., Dragomir, A., Perreault, S., Moore, N. D., & Moride, Y. (2012) · Neurology · doi:10.1212/wnl.0b013e31824d5773 · Cited by 28
Yanagihara, T. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04795.x · Cited by 28
Ishii, H., Meguro, K., Yamaguchi, S., Ishikawa, H., & Yamadori, A. (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01781.x · Cited by 27
Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients
Yasunori, Y., Miwa, T., Sakurai, H., Hanyu, H., Iwamoto, T., & Odawara, M. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-388 · Cited by 27
“77 times more than those in subjects without diabetes [1].”
BackgroundPrevention strategies for Alzheimer’s disease
Gauthier, S. G., Wu, L., Rosa‐Neto, P., & Jia, J. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-13 · Cited by 31
Fung, A. W. T., Lee, A. T. C., Cheng, S., & Lam, L. C. W. (2018) · International Psychogeriatrics · doi:10.1017/s1041610218001333 · Cited by 27
Vascular Risk Factors and Alzheimer's Disease
Stewart, R. J., Prince, M. J., & MANN, A. H. (1999) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00657.x · Cited by 26
Hypertension, Cognitive Impairment and Dementia: An Epidemiological Perspective
Reitz, C., & Luchsinger, J. A. (2007) · Current Hypertension Reviews · doi:10.2174/157340207781386747 · Cited by 30
Pan, Q., Guo, K., Xue, M., & Tu, Q. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104685 · Cited by 25
Marra, M. L., Villano, I., Ilardi, C. R., Carosella, M., Staiano, M., Iavarone, A., Chieffi, S., Messina, G., Polito, R., Porro, C., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12060777 · Cited by 27
Barloese, M. C. J., Bauer, C., Petersen, E. T., Hansen, C. S., Madsbad, S., & Siebner, H. R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.874007 · Cited by 34
Clinical analysis of cognitive function in diabetic patients by MMSE and SPECT
Niwa, H., Koumoto, C., Shiga, T., Takeuchi, J., Mishima, S., Segawa, T., Atsumi, T., Shimizu, C., Koike, T., & Yoshioka, N. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.10.012 · Cited by 26
ALZHEIMER'S DISEASE AND VASCULAR FACTORS: FACTS AND THEORIES
Pansari, K., Gupta, A., & Thomas, P. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11233.x · Cited by 27
Akiguchi, I., Tomimoto, H., Wakita, H., Kawamoto, Y., Matsuo, A., Ohnishi, K., Watanabe, T., & Budka, H. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0850-2 · Cited by 25
Body mass index and stroke incidence in a Japanese community: the Hisayama study
Yonemoto, K., Doi, Y., Hata, J., Ninomiya, T., Fukuhara, M., Ikeda, F., Mukai, N., Iida, M., & Kiyohara, Y. (2010) · Hypertension Research · doi:10.1038/hr.2010.220 · Cited by 25
Self-citationZhang, Y., Zhang, Z., Yang, B., Li, Y., Zhang, Q., Qu, Q., Wang, Y., Zhang, S., Yue, W., Tan, Y., et al. (2012) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-012-1056-9 · Cited by 26
Diabetes and the elderly brain: sweet memories?
Samaras, K., & Sachdev, P. S. (2012) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018812469645 · Cited by 28
Hematologic Risk Factors of Vascular Disease and Their Relation to Dementia
Mielke, M. M., & Zandi, P. P. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000091789 · Cited by 24
Shimizu, N., Umemura, T., Matsunaga, M., & Hirai, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187480 · Cited by 25
Are vascular factors involved in Alzheimer’s disease? Facts and theories
Iorio, A. D., Zito, M., Lupinetti, M. C., & Abate, G. (1999) · Aging Clinical and Experimental Research · doi:10.1007/bf03339811 · Cited by 25
Yamada, M., Mimori, Y., Kasagi, F., Miyachi, T., Ohshita, T., & Sasaki, H. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.338 · Cited by 24
“Results regarding risk factors, however, have not been consistent [10–16].”
ResultShimizu, H., Mori, T., Yoshida, T., Tachibana, A., Ozaki, T., Yoshino, Y., Ochi, S., Sonobe, N., Matsumoto, T., Komori, K., et al. (2022) · Psychogeriatrics · doi:10.1111/psyg.12865 · Cited by 24
Marra, M. L., Ilardi, C. R., Villano, I., Carosella, M., Staiano, M., Iavarone, A., Chieffi, S., Messina, G., Polito, R., Scarinci, A., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12081080 · Cited by 30
Gallacher, J., Pickering, J. E., Elwood, P. C., Bayer, A. J., YARNELL, J. W. G., & Ben‐Shlomo, Y. (2005) · European Journal of Epidemiology · doi:10.1007/s10654-005-2146-9 · Cited by 24
“These data also suggest that although associations of diabetes with dementia [14, 18, 21, 31] illustrate the long term global impact of diabetes, they provides no information on the susceptibility of specific cognitive domains.”
BackgroundResultAlzheimer's disease: epidemiology
Mayeux, R. P. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01218-3 · Cited by 25
Mammalian Target of Rapamycin at the Crossroad Between Alzheimer’s Disease and Diabetes
Liang, H., Nie, J., Skike, C. E. V., Valentine, J. M., & Orr, M. E. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_10 · Cited by 24
Cortisol: Mediator of association between Alzheimer’s disease and diabetes mellitus?
Notarianni, E. L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.008 · Cited by 23
Alcohol consumption and incident dementia in older Japanese adults: The Okayama Study
Liu, Y., Mitsuhashi, T., Yamakawa, M., Sasai, M., Tsuda, T., Doi, H., & Hamada, J. (2019) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13694 · Cited by 22
Alcohol consumption and risk of Alzheimer's disease: A dose–response meta‐analysis
Xie, C., & Feng, Y. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14357 · Cited by 24
Risk factors for dementia in a rural area of Northeastern Brazil
Magalhães, M. O. D. C., Peixoto, J. M. D. S., Frank, M. H., Gomes, I., Rodrigues, B. M., Menezes, C., Cardoso, E., Carvalho, F. M., Aras, R., & Melo, A. D. S. (2008) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2008000200003 · Cited by 23
Intercontinental Epidemiology of Alzheimer Disease
Farrer, L. A. (2001) · JAMA · doi:10.1001/jama.285.6.796 · Cited by 23
“The influence of stroke risk factors and coincident cerebrovascular disease on incident dementia also may vary by ethnic background,(35,36) as suggested by studies of US African American,(36) Hispanic,(37) and Japanese persons.(38) In light of the recognition by Hendrie et al of the lower prevalence of vascular risk f…”
BackgroundPhysical activity and risk of cognitive impairment among older persons living in the community
Landi, F., Russo, A., Barillaro, C., Cesari, M., Pahor, M., Danese, P., Bernabei, R., & Onder, G. (2007) · Aging Clinical and Experimental Research · doi:10.1007/bf03324723 · Cited by 22
Prevention of Alzheimer disease. Encouraging evidence.
Scalco, M. Z., & van Reekum, R. (2006) · Europe PMC (PubMed Central) · Cited by 22
Metadata
- Authors
- Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., Ohmori, S., Nomiyama, K., Kawano, H., Ueda, K., Sueishi, K., Tsuneyoshi, M., & Fujishima, M.
- Affiliations
- Kyushu University (JP)
- Venue
- Neurology
- Published
- 1995-06
- Volume
- 45
- Issue
- 6
- Pages
- 1161-1168
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2147954981
- Cited by
- 829
- References
- 0
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 14 · 2023: 11 · 2022: 22 · 2021: 18 · 2020: 24 · 2019: 20 · 2018: 16 · 2017: 31 · 2016: 27 · 2015: 29 · 2014: 27 · 2013: 28 · 2012: 35
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- vascular dementia, Alzheimer's disease, dementia incidence, risk factors, asymptomatic stroke, lacunar infarction, systolic blood pressure, alcohol consumption, physical activity, Hasegawa Dementia Scale
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Cerebrovascular Disorders, Female, Humans, Japan, Male, Risk Factors, Dementia, Vascular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review